Evommune, Inc. (EVMN) stock
EVMNNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$7.02−0.08 (-1.13%)
Close on Nov 17, 2026Market cap $254.77MP/E –Yield –
Evommune total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
No total debt figures for Evommune
Evommune has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?